These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Apheresis in patients with severe sepsis and multi organ dysfunction syndrome. Stegmayr B Transfus Apher Sci; 2008 Jun; 38(3):203-8. PubMed ID: 18492616 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms underlying the beneficial effects of stem cell therapies for inflammatory bowel diseases. Panés J; Salas A Gut; 2009 Jul; 58(7):898-900. PubMed ID: 19520885 [No Abstract] [Full Text] [Related]
4. Plasma exchange in multiple organ failure: changing gears in sepsis and organ failure. Cuhaci B Crit Care Med; 2003 Jun; 31(6):1875-7. PubMed ID: 12794441 [No Abstract] [Full Text] [Related]
5. Immunoadsorption in patients with dilated cardiomyopathy. Herda LR; Felix SB; Staudt A Atheroscler Suppl; 2009 Dec; 10(5):126-8. PubMed ID: 20129390 [TBL] [Abstract][Full Text] [Related]
6. 2008 Congress of the ESFH in Düsseldorf, Germany. Moog R Transfus Apher Sci; 2009 Aug; 41(1):23-6. PubMed ID: 19556166 [No Abstract] [Full Text] [Related]
7. Plasma exchange treatment to reduce anti-beta1-adrenergic receptor antibody in a patient with dilated cardiomyopathy. Gesinde MO; Tan LB; Gooi HC J Clin Apher; 2007; 22(4):241-2. PubMed ID: 17385717 [No Abstract] [Full Text] [Related]
9. The coagulant response in sepsis. Levi M Clin Chest Med; 2008 Dec; 29(4):627-42, viii. PubMed ID: 18954698 [TBL] [Abstract][Full Text] [Related]
10. Apheresis as therapy for patients with severe sepsis and multiorgan dysfunction syndrome. Stegmayr BG Ther Apher; 2001 Apr; 5(2):123-7. PubMed ID: 11354296 [TBL] [Abstract][Full Text] [Related]
11. Multiple organ failure--a role for plasma exchange? McClelland P; Williams PS; Yaqoob M; Mostafa SM; Bone JM Intensive Care Med; 1990; 16(2):100-3. PubMed ID: 2332535 [TBL] [Abstract][Full Text] [Related]
12. Myocarditis and dilated cardiomyopathy: possible connections and treatments. Castellano G; Affuso F; Di Conza P; Fazio S J Cardiovasc Med (Hagerstown); 2008 Jul; 9(7):666-71. PubMed ID: 18545064 [TBL] [Abstract][Full Text] [Related]
13. Removal of pathogenic autoantibodies by immunoadsorption. Hershko AY; Naparstek Y Ann N Y Acad Sci; 2005 Jun; 1051():635-46. PubMed ID: 16127004 [TBL] [Abstract][Full Text] [Related]
14. Autoimmunity, immunoglobulin adsorption and dilated cardiomyopathy: has the time come for randomized clinical trials? Mann DL J Am Coll Cardiol; 2001 Jul; 38(1):184-6. PubMed ID: 11451271 [No Abstract] [Full Text] [Related]
15. Autoimmunity and idiopathic dilated cardiomyopathy: where we stand? Fu M Autoimmunity; 2008 Sep; 41(6):415-8. PubMed ID: 18781466 [TBL] [Abstract][Full Text] [Related]
16. Immunoadsorption as treatment option in dilated cardiomyopathy. Felix SB; Staudt A Autoimmunity; 2008 Sep; 41(6):484-9. PubMed ID: 18781476 [TBL] [Abstract][Full Text] [Related]
17. Thrombocytopenia-associated multiple-organ failure (TAMOF): recognition and management. Ramsi M; Al Ali AS BMJ Case Rep; 2018 Aug; 2018():. PubMed ID: 30150343 [TBL] [Abstract][Full Text] [Related]
18. Metabolic support in sepsis and multiple organ failure. Herndon DN; Wernerman J Crit Care Med; 2007 Sep; 35(9 Suppl):S435. PubMed ID: 17713389 [No Abstract] [Full Text] [Related]
19. Effects of protein A immunoadsorption in patients with advanced chronic dilated cardiomyopathy. Doesch AO; Konstandin M; Celik S; Kristen A; Frankenstein L; Hardt S; Goeser S; Kaya Z; Katus HA; Dengler TJ J Clin Apher; 2009; 24(4):141-9. PubMed ID: 19591221 [TBL] [Abstract][Full Text] [Related]
20. Apheresis of plasma compounds as a therapeutic principle in severe sepsis and multiorgan dysfunction syndrome. Stegmayr B Clin Chem Lab Med; 1999 Mar; 37(3):327-32. PubMed ID: 10353479 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]